Latest Conference Articles

How MR Fingerprinting Can Improve Epilepsy Surgery: Irene Wang, PhD

How MR Fingerprinting Can Improve Epilepsy Surgery: Irene Wang, PhD

January 25th 2022, 2:00pm

Cleveland Clinic

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center detailed the clinical pre- and post-surgery benefits patients with epilepsy get from MR fingerprinting. [WATCH TIME: 3 minutes]

Expanding the Use of Seizure Apps for Epilepsy: Jessica Fesler, MD, MEd

Expanding the Use of Seizure Apps for Epilepsy: Jessica Fesler, MD, MEd

January 24th 2022, 6:00pm

Cleveland Clinic

The staff epileptologist at Cleveland Clinic’s Epilepsy Center discussed new untapped ways seizure apps could help patients with epilepsy. [WATCH TIME: 2 minutes]

Use of Seizure Apps During the Pandemic, Need for Data: Jessica Fesler, MD, MEd

Use of Seizure Apps During the Pandemic, Need for Data: Jessica Fesler, MD, MEd

January 21st 2022, 2:00pm

Cleveland Clinic

The staff epileptologist at Cleveland Clinic’s Epilepsy Center gave her expert opinion on whether seizure app usage has increased during the COVID-19 pandemic and why there remains a need for further data collections. [WATCH TIME: 2 minutes]

Capabilities and Limitations of Seizure Apps: Jessica Fesler, MD, MEd

Capabilities and Limitations of Seizure Apps: Jessica Fesler, MD, MEd

January 19th 2022, 2:00pm

Cleveland Clinic

The staff epileptologist at Cleveland Clinic’s Epilepsy Center detailed the benefits seizure apps provide for patients with epilepsy, as well as the barriers that limit them. [WATCH TIME: 3 minutes]

NeuroVoices: Irene Wang, PhD, on the Future of MR Fingerprinting and its Impact on Epilepsy Surgery

NeuroVoices: Irene Wang, PhD, on the Future of MR Fingerprinting and its Impact on Epilepsy Surgery

January 19th 2022, 12:00pm

Cleveland Clinic

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided an inside look at the ways MR fingerprinting can provide real-time clinical benefit for physicians and patient care.

Advantages and Potential of MR Fingerprinting in Epilepsy, Neurology: Irene Wang, PhD

Advantages and Potential of MR Fingerprinting in Epilepsy, Neurology: Irene Wang, PhD

January 18th 2022, 2:00pm

Cleveland Clinic

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed opportunities for MR fingerprinting to expand, both in the epilepsy field and in general neurology. [WATCH TIME 3 minutes]

Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD

Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD

January 14th 2022, 6:00pm

Cleveland Clinic

The clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]

Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD

Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD

January 13th 2022, 6:00pm

Cleveland Clinic

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided insight on her study presented at AES 2021, which showed that MR fingerprinting can differentiate focal cortical dysplasia from healthy tissue. [WATCH TIME: 4 minutes]

NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy

NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy

January 12th 2022, 12:00pm

Cleveland Clinic

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.

Newborn Screening, mTOR Pathway May Offer New Hope for Tuberous Sclerosis

Newborn Screening, mTOR Pathway May Offer New Hope for Tuberous Sclerosis

January 11th 2022, 12:00pm

TSC Alliance

Darcy Krueger, MD, PhD, director, Tuberous Sclerosis Clinic, Cincinnati Children’s, discussed the idea behind swiftly treating tuberous sclerosis at infant stages using targeted therapeutic approaches.